Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
High-efficiency preambles for communications systems over pseudo-stationary communication channels
Remote device pairing setup
Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate
Methods and apparatus to perform time zone determination by a mobile station
Selecting content for storage in a multi-device cache
Transistor and display device
Image decolorizing device
  Randomly Featured Patents
Process for the production of L-amino acids
Reusable multipack for stacked wound rolls
Roadway structure having improved adhesive properties
Shadow RAM cell using a ferroelectric capacitor
Olefin separation process
Methods for the isolation and purification of the recombinantly expressed chondroitinase I and II enzymes from P. vulgaris
Receipt constitution of center facia panel
Immobilization of materials
Apparatus and method for growing nitride semiconductor crystal film
True position sensor for diaphragm valves using reflected light property variation